Logo image
Head and neck cancers: Clinical practice guidelines
Journal article   Peer reviewed

Head and neck cancers: Clinical practice guidelines

Arlene A. Forastiere, Kian Ang, David Brizel, Bruce Earl Brockstein, Frank Dunphy, David W. Eisele, Helmuth Goepfert, Wesley L. Hicks, Merrill S. Kies, William M. Lydiatt, …
Journal of the National Comprehensive Cancer Network, Vol.3(3), pp.316-391
2005
DOI: 10.6004/jnccn.2005.0019
url
https://doi.org/10.6004/jnccn.2005.0019View
Published (Version of record) Open Access

Abstract

The NCCN Head and Neck Cancers guidelines address tumors arising in the lip, oral cavity, oropharynx, hypopharynx, glottic and supraglottic larynx, paranasal (ethmoid and maxillary) sinuses, nasopharynx, and salivary glands, as well as occult primary cancer. Approximately 39,250 new cases of oral cavity, pharyngeal, and laryngeal cancers will occur in 2005, which accounts for about 3% of new cancer cases in the United States. An estimated 11,090 deaths from head and neck (H&N) cancers will occur in 2005. Alcohol and tobacco abuse are common etiologic factors in cancers of the oral cavity, oropharynx, hypopharynx, and larynx. Moreover, because the entire aerodigestive tract epithelium may be exposed to these carcinogens, patients with H&N cancer are at risk for developing second primary neoplasms of the H&N, lung, and esophagus.
Chemotherapy Radiotherapy Head and neck cancer Hypopharynx Larynx Lip NCCN Clinical Practice Guidelines Oral cavity Oropharynx Salivary glands Sinuses Surgery carcinoma

Details

Metrics

9 Record Views
Logo image